All (3)News (3)Transcripts (0)Press Releases (0)

News112 days ago

Cyclacel Pharmaceuticals Highlights Promising Preclinical Data

Cyclacel Pharmaceuticals shares are trading higher after highlighting preclinical data showing that their drug plogosertib is effective against biliary tract cancer.

News145 days ago

Cyclacel's Reverse Stock Split Sparks Concerns

Cyclacel Pharmaceuticals shares are trading lower after the company announced a 1-for-15 reverse stock split, raising concerns about its financial stability and market valuation.

News210 days ago

Cyclacel Pharmaceuticals Faces Stock Pressure Amid Subsidiary Liquidation

Cyclacel Pharmaceuticals shares are trading lower after announcing the liquidation of its subsidiary, Cyclacel Limited, resulting in a focus shift to developing plogosertib for cancer treatment and anticipated decreased R&D expenses.